PURETECH HEALTH PLC ORD 1P chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.06
Dividend & YieldN/A£ (N/A)
Beta 0.94
Market capitalization 647.87M
Operating cash flow -180.16M
ESG Scores unknown

Company description

PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions. It also provides hematopoietic stem cell based therapies for patients with blood cancer; a voice-based technology platform to detect voice changes linked to health conditions; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100 to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210 to treat solid tumors; Glyph, a synthetic lymphatic targeting chemistry platform; Orasome technology to enable the oral administration of macromolecule therapeutic payloads; meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases; and Alivio technology platform for inflammation-targeted disease immunomodulation. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio2.22
Working Capital-0.22
Return On Equity-0.1
Debt To Equity0.02
Fixed Asset Ratio0
Fixed Interest Cover-31.88

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 9.94M 11.35M -4.62M 6.93M
Total Cashflows From Investing Activities -39.65M 63.66M 364.48M 197.38M
Net Borrowings 5.96M -250k 36.88M -1.16M
Total Cash From Financing Activities 156.89M 49.91M 38.87M 22.73M
Change To Operating Activities -438k 2.93M -3.38M -5.45M
Issuance Of Stock 97.49M 504k 1.04M 352k
Net Income -43.65M 421.14M 5.99M -60.56M
Change In Cash 44.4M 15.31M 271.52M 61.83M
Effect Of Exchange Rate -44k -104k
Total Cash From Operating Activities -72.8M -98.16M -131.83M -158.27M
Depreciation 2.78M 6.67M 6.64M 7.29M
Change To Account Receivables 467k 747k -529k -617k
Other Cashflows From Financing Activities 53.47M 50.94M 953k 26.12M
Change To Netincome -41.88M -540.99M -135.93M -105.86M
Capital Expenditures -4.37M -12.14M -5.17M -5.57M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 77.4M 85.85M 81.86M 110.47M
Income Before Tax -68.44M 478.47M 18.97M -58.95M
Net Income -43.65M 421.14M 5.99M -60.56M
Selling General Administrative 47.37M 59.36M 49.44M 57.2M
Gross Profit -56.65M 9.81M 11.77M 17.39M
Ebit -104.02M -135.4M -119.53M -150.28M
Operating Income -104.02M -135.4M -119.53M -150.28M
Interest Expense -498k -4.1M -2.95M -4.71M
Income Tax Expense 2.22M 112.41M 14.4M 3.76M
Total Revenue 20.75M 9.81M 11.77M 17.39M
Cost Of Revenue 77.4M
Total Other Income ExpenseNet 35.58M 613.87M 138.5M 91.33M
Net Income From Continuing Ops -70.66M 366.06M 4.57M -62.71M
Net Income Applicable To Common Shares -43.65M 421.14M 5.99M -60.56M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 274.79M 290.78M 336.45M 361.86M
Total Stockholder Equity 275.51M 668.04M 669.75M 593.51M
Other Current Liabilities 237.88M 114.67M 132.75M 183.46M
Total Assets 441.76M 941.18M 989.99M 946.01M
Common Stock 5.38M 5.41M 5.42M 5.44M
Other Current Assets 2.2M 2.12M 2.12M 2.12M
Retained Earnings -167.69M 254.44M 260.43M 199.87M
Treasury Stock 159.44M 120.22M 114.92M 98.9M
Cash 117.05M 132.36M 403.88M 465.71M
Total Current Liabilities 265.76M 139.2M 180.92M 226.13M
Other Stockholder Equity 159.44M 120.22M 114.92M 98.9M
Property, Plant, and Equipment 8.32M 43.84M 42.88M 43.94M
Total Current Assets 259.79M 168.84M 414.35M 501.81M
Net Tangible Assets 272.43M 667.41M 668.85M 592.53M
Net Receivables 1.33M 2.33M 2.94M 23.22M
Accounts Payable 4.64M 11.1M 8.87M 11.35M


Insider Transactions

Here are the insider transactions of stock shares related to PURETECH HEALTH PLC ORD 1P:

Filer Name Transaction Text Ownership Date Filer Relation Shares
PureTech Health PLCBuy Back at price 2.59 per share.D2022-10-20229.14k
PureTech Health PLCBuy Back at price 2.61 per share.D2022-10-19177.07k
PureTech Health PLCBuy Back at price 2.59 per share.D2022-10-1838
PureTech Health PLCBuy Back at price 2.59 per share.D2022-10-1782.22k
PureTech Health PLCBuy Back at price 2.50 per share.D2022-10-14273.46k
PureTech Health PLCBuy Back at price 2.46 per share.D2022-10-13271.64k
PureTech Health PLCBuy Back at price 2.40 per share.D2022-10-12264.86k
PureTech Health PLCBuy Back at price 2.38 per share.D2022-10-11253.27k
PureTech Health PLCBuy Back at price 2.48 per share.D2022-10-10245.71k
Ruffer LLPBought at price 2.40 per share.D2022-10-10272.39k
Lansdowne Partners Ltd PartnershipSold at price 2.49 per share.D2022-10-108.8k
Lansdowne Partners Ltd PartnershipSold at price 2.46 per share.D2022-10-078.85k
M&G Alternatives Investment Management, Ltd.D2022-10-07450.38k
Baillie Gifford & CoD2022-10-078.56M
BlackRock Investment Management (UK) Ltd.D2022-10-07
Geode Capital Management, L.L.C.D2022-10-07
Hargreave Hale LtdD2022-10-07
Invesco, Ltd.Bought at price 2.53 per share.D2022-10-075.14k
J O Hambro Capital Management LtdBought at price 2.37 per share.D2022-10-07373.8k
PureTech Health PLCBuy Back at price 2.44 per share.D2022-10-07203.84k
PureTech Health PLCBuy Back at price 2.80 per share.D2022-10-06183.38k
Vanguard Group Inc.D2022-10-06
Investec Asset Management LtdD2022-10-06
Kempen Capital Management N.V.D2022-10-06
PureTech Health PLCBuy Back at price 2.76 per share.D2022-10-05176.49k
PureTech Health PLCBuy Back at price 2.80 per share.D2022-10-04167.05k
PureTech Health PLCBuy Back at price 2.74 per share.D2022-10-03158.53k
PureTech Health PLCBuy Back at price 2.65 per share.D2022-09-3051.26k
PureTech Health PLCBuy Back at price 2.43 per share.D2022-09-2873.24k
PureTech Health PLCBuy Back at price 2.32 per share.D2022-09-27114.91k
PureTech Health PLCBuy Back at price 2.31 per share.D2022-09-26114.35k
PureTech Health PLCBuy Back at price 2.37 per share.D2022-09-23112.33k
PureTech Health PLCBuy Back at price 2.49 per share.D2022-09-22113.37k
PureTech Health PLCBuy Back at price 2.55 per share.D2022-09-21113.62k
PureTech Health PLCBuy Back at price 2.72 per share.D2022-09-20109.5k
PureTech Health PLCBuy Back at price 2.86 per share.D2022-09-1671.41k
PureTech Health PLCBuy Back at price 2.88 per share.D2022-09-1570.25k
PureTech Health PLCBuy Back at price 2.88 per share.D2022-09-1468.27k
PureTech Health PLCBuy Back at price 2.88 per share.D2022-09-1373.67k
PureTech Health PLCBuy Back at price 2.93 per share.D2022-09-1272.15k
PureTech Health PLCBuy Back at price 2.91 per share.D2022-09-0973.75k
PureTech Health PLCBuy Back at price 2.85 per share.D2022-09-0876.52k
PureTech Health PLCBuy Back at price 2.87 per share.D2022-09-0776.61k
PureTech Health PLCBuy Back at price 2.89 per share.D2022-09-0678.6k
PureTech Health PLCBuy Back at price 2.84 per share.D2022-09-0563.93k
PureTech Health PLCBuy Back at price 2.89 per share.D2022-09-0279.61k
PureTech Health PLCBuy Back at price 2.78 per share.D2022-09-0176.17k
PureTech Health PLCBuy Back at price 2.92 per share.D2022-08-3175.67k
PureTech Health PLCBuy Back at price 2.79 per share.D2022-08-3075.71k
PureTech Health PLCBuy Back at price 2.94 per share.D2022-08-2673.63k
PureTech Health PLCBuy Back at price 2.96 per share.D2022-08-2569.73k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to PURETECH HEALTH PLC ORD 1P. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on PURETECH HEALTH PLC ORD 1P

Here is the result of two systematic investment strategies applied to PURETECH HEALTH PLC ORD 1P. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on PURETECH HEALTH PLC ORD 1P

The following chart shows the equity curve of the two systematic investment strategies applied to PURETECH HEALTH PLC ORD 1P:

PURETECH HEALTH PLC ORD 1P automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 30.93% on the backtest period.

Performance at glance

Performance

30.93 %

Latent gain

709.0 £

Invested capital

2292.5 £

Annualized return

7.51 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on PURETECH HEALTH PLC ORD 1P

This is the result of two momentum investment strategies applied to PURETECH HEALTH PLC ORD 1P. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on PURETECH HEALTH PLC ORD 1P

The following chart shows all the entries opened by the momentum investment system on PURETECH HEALTH PLC ORD 1P:

PURETECH HEALTH PLC ORD 1P momentum entries
  • The first momentum investment strategy would give 48.15% of return on PURETECH HEALTH PLC ORD 1P. That represents 3035.0£ of latent gain with 6303.0£ of employed capital.
  • The second momentum investment strategy would give 57.39% of return on PURETECH HEALTH PLC ORD 1P. That represents 1824.0£ of latent gain with 3178.5£ of employed capital.
Performance at glance (1Q Momentum)

Performance

48.15 %

Latent gain

3035.0 £

Invested capital

6303.0 £

Annualized return

22.75 %
Performance at glance (2Q Momentum)

Performance

57.39 %

Latent gain

1824.0 £

Invested capital

3178.5 £

Annualized return

15.77 %

Momentum equity curve on PURETECH HEALTH PLC ORD 1P

The following chart shows the equity curve of the two momentum strategies applied to PURETECH HEALTH PLC ORD 1P:

PURETECH HEALTH PLC ORD 1P momentum equity

Note: the dividends potentially given by PURETECH HEALTH PLC ORD 1P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on PURETECH HEALTH PLC ORD 1P

The following chart shows the employed capital evolution of the two momentum strategies on PURETECH HEALTH PLC ORD 1P since the beginning:

PURETECH HEALTH PLC ORD 1P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on PURETECH HEALTH PLC ORD 1P

Buy the dip entry openings on PURETECH HEALTH PLC ORD 1P

PURETECH HEALTH PLC ORD 1P

The performance achieved by the robo-advisor on PURETECH HEALTH PLC ORD 1P is 48.22%. That represents 108.5$ of latent gain with 225.0£ of employed capital. The following chart shows PURETECH HEALTH PLC ORD 1P stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of PURETECH HEALTH PLC ORD 1P, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

48.22 %

Latent gain

108.5 £

Invested capital

225.0 £

Annualized return

22.75 %

Equity curve of the strategy applied to PURETECH HEALTH PLC ORD 1P

The following chart shows the result of the investment strategy applied to PURETECH HEALTH PLC ORD 1P:

PURETECH HEALTH PLC ORD 1P

Note: the dividends potentially given by PURETECH HEALTH PLC ORD 1P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on PURETECH HEALTH PLC ORD 1P

The following chart shows the employed capital evolution since the beginning of the investment strategy on PURETECH HEALTH PLC ORD 1P:

PURETECH HEALTH PLC ORD 1P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on PURETECH HEALTH PLC ORD 1P

In this section, I will compare the three previous investment strategies applied to PURETECH HEALTH PLC ORD 1P.

Equity curve comparison on PURETECH HEALTH PLC ORD 1P

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

PURETECH HEALTH PLC ORD 1P investment strategy comparison

Employed capital comparison on PURETECH HEALTH PLC ORD 1P

PURETECH HEALTH PLC ORD 1P investment comparison

Performance comparison on PURETECH HEALTH PLC ORD 1P

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 30.93% 709.0£ 2292.5£ 7.51%
Momentum 1 quarter 48.15% 3035.0£ 6303.0£ 12.41%
Momentum 2 quarters 57.39% 1824.0£ 3178.5£ 15.77%
Non-directional 48.22% 108.5£ 225.0£ 22.75%
Annualized return comparison

Automatic investment

7.51 %

Momentum 1Q

15.77 %

Momentum 2Q

15.77 %

Non-directional

22.75 %

Correlated stocks

Here are the most positively and negatively correlated stocks with PURETECH HEALTH PLC ORD 1P:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between PURETECH HEALTH PLC ORD 1P and the other stocks. There may be false positives or some missing correlated stocks. If the price of PURETECH HEALTH PLC ORD 1P does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name PURETECH HEALTH PLC ORD 1P
Country United States
City Boston
Address 6 Tide Street
Phone 617 482 2333
Website www.puretechhealth.com
FullTime employees 95
Industry Biotechnology
Sector Healthcare
Exchange XLON
Ticker PRTC.XLON
Market www.londonstockexchange.com

PURETECH HEALTH PLC ORD 1P ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown